<DOC>
	<DOCNO>NCT00642382</DOCNO>
	<brief_summary>The purpose study determine whether Agilus safe effective treatment mild moderate ankle osteoarthritis .</brief_summary>
	<brief_title>Safety Effectiveness Agilus ( Hyaluronic Acid ) Ankle Osteoarthritis</brief_title>
	<detailed_description>The objective study compare safety effectiveness Agilus saline injection ( control ) treatment mild moderate ankle osteoarthritis . This multi-center , randomize , double blind , saline control , prospective study two ( 2 ) treatment group . The active group receive one injection Agilus per week three consecutive week total three injection . The control group receive one injection normal saline per week three consecutive week total three injection . Follow visit occur 4 week , 12 week 26 week follow third injection .</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Hyaluronic Acid</mesh_term>
	<criteria>18 year old Chronic , unilateral ankle pain ( i.e. , one ankle ) least 6 month Diagnosis ankle OA confirm radiograph ( Xray ) clinical exam Are normally active , without aid mobility device ( crutch , walker cane ) Have use oral steroid within 30 day ( inhaled topical steroid acceptable ) Have receive intraarticular injection hyaluronic acid joint last 9 month Have receive steroid injection joint last 3 month Have previous surgery arthroscopy affect ankle last 12 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Osteoarthritis</keyword>
	<keyword>Hyaluronic Acid</keyword>
</DOC>